Ana Radeljevic
Director/Board Member at MERRIMACK PHARMACEUTICALS, INC.
Profile
Ana Radeljevic is currently the Chief Executive Officer at Adventus Partners since 2016.
She is also an Independent Director at Merrimack Pharmaceuticals, Inc. since 2022 and the Chief Business Officer at ADRx, Inc. since 2021.
Previously, she worked as the Vice President-Financial Planning & Analysis at Revvity, Inc. from 2014 to 2016.
Ms. Radeljevic holds an MBA from Syracuse University and an undergraduate degree from Old Dominion University.
Ana Radeljevic active positions
| Companies | Position | Start |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Director/Board Member | 2022-06-05 |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2021-08-31 |
Former positions of Ana Radeljevic
| Companies | Position | End |
|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 2015-12-31 |
Training of Ana Radeljevic
| Syracuse University | Masters Business Admin |
| Old Dominion University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Ana Radeljevic
